[New findings on human prolactin].
Since prolactin (HPRL) occurs as a separate pituitary hormone in man the paper will discuss results about the mechanisms involved regulation of HPRL secretion. A number of factors which lead to an increase in HPRL secretion are named. The clinical relevance of HPRL inhibiting substances as L-DOPA and 2-Br-alpha-ergocryptine is mentioned. The influence of HPRL in pregnancy and lactation period is described also the regulative effect of HPRL on hormone-dependent breast tumors.
D000568:Amenorrhea / Q000503:physiopathology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology; D006801:Humans; D007031:Hypothalamus / Q000502:physiology; D007037:Hypothyroidism / Q000503:physiopathology; D007774:Lactation; D011247:Pregnancy; D011388:Prolactin / Q000502:physiology*; D011389:Prolactin Release-Inhibiting Factors / Q000502:physiology; D012507:Sarcoidosis / Q000503:physiopathology; D013973:Thyrotropin-Releasing Hormone / Q000502:physiology
D007987:Gonadotropin-Releasing Hormone; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D011389:Prolactin Release-Inhibiting Factors
Neuere Erkenntnisse über das menschliche Prolaktin